Stephen J. Brandt0000-0003-2184-8281
Stephen Brandt was born in Atlanta, Ga, USA in 1954. He received a B.S. degree (summa cum laude) in zoology from Duke University in 1976 and an M.D. degree (magna cum laude) from Emory University in 1981. Following residency training in internal medicine at the University of Virginia Health Sciences Center and fellowship training in Hematology-Oncology at Duke University, he obtained postdoctoral training at the National Heart, Lung, and Blood Institute before joining the Vanderbilt University faculty in 1990. He is a Professor of medicine, cell and developmental biology, and cancer biology at Vanderbilt and also serves as Staff Hematologist at the Nashville VA Medical Center and as Medical Director of the Conjoint Vanderbilt-VA Stem Cell Transplant Processing Laboratory. His laboratory is engaged in studies of normal and malignant hematopoiesis and has been particularly interested in the function and regulation of the basic-helix-loop-helix transcription factor TAL1 (or SCL), LIM domain protein LMO2, LIM domain-binding protein LDB1, and LDB1-interacting proteins SSBP2 and SSBP3. Dr. Brandt’s clinical and translational research efforts are related to hematopoietic stem cell transplantation and have addressed the derivation of circulating endothelial progenitors in allogeneic stem cell transplant recipients and pharmacogenetic determinants of toxicity after high-dose chemotherapy of multiple myeloma.
Biography Updated on 12 January 2011